Global Duchenne Muscular Dystrophy Market Report 2020, Forecast to 2025

February 2020 | 118 pages | ID: G241890F7105EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The report forecast global Duchenne Muscular Dystrophy market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on vendors' revenue. Estimates of the regional markets for Duchenne Muscular Dystrophy are based on the applications market.

The report offers detailed coverage of Duchenne Muscular Dystrophy industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Duchenne Muscular Dystrophy by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Duchenne Muscular Dystrophy market are discussed.

The market is segmented by types:

• Pain Management Drugs
• Corticosteroids
• Prednisolone
• Prednisone
• Deflazacort

It can be also divided by applications:

• Hospitals
• Clinics
• Home Care Settings

And this report covers the historical situation, present status and the future prospects of the global Duchenne Muscular Dystrophy market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Bristol-Myers Squibb
• FibroGen (U.S.)
• Italfarmaco (Italy)
• Marathon
• NS Pharma (U.S.)
• PTC Therapeutics (U.S.)
• Pfizer
• ReveraGen BioPharma (U.S.)
• Santhera Pharmaceuticals (Switzerland)
• Sarepta Therapeutics (U.S.)

Report Includes:

• xx data tables and xx additional tables
• An overview of global Duchenne Muscular Dystrophy market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Duchenne Muscular Dystrophy market
• Profiles of major players in the industry, including Bristol-Myers Squibb, FibroGen (U.S.), Italfarmaco (Italy), Marathon, NS Pharma (U.S.).....

Research objectives

• To study and analyze the global Duchenne Muscular Dystrophy consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Duchenne Muscular Dystrophy market by identifying its various subsegments.
• Focuses on the key global Duchenne Muscular Dystrophy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Duchenne Muscular Dystrophy with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Duchenne Muscular Dystrophy submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Duchenne Muscular Dystrophy Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Duchenne Muscular Dystrophy Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 DUCHENNE MUSCULAR DYSTROPHY INDUSTRY OVERVIEW

2.1 Global Duchenne Muscular Dystrophy Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Duchenne Muscular Dystrophy Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Pain Management Drugs
  2.2.2 Corticosteroids
  2.2.3 Prednisolone
  2.2.4 Prednisone
  2.2.5 Deflazacort
  2.3.2 Clinics
  2.3.3 Home Care Settings
  2.4.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Duchenne Muscular Dystrophy Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Duchenne Muscular Dystrophy Manufacturer Market Share
  2.4.5 Top 10 Duchenne Muscular Dystrophy Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Duchenne Muscular Dystrophy Market
  2.4.7 Key Manufacturers Duchenne Muscular Dystrophy Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Duchenne Muscular Dystrophy Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis

3 RELATED MARKET ANALYSIS

3.1 Related Market Overview
3.2 Macro Analysis of Upstream Markets
3.3 Key Players in Related Markets
3.4 Related Markets Trend Analysis

4 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET SIZE CATEGORIZED BY REGIONS

4.1 Global Duchenne Muscular Dystrophy Revenue and Market Share by Regions
  4.1.1 Global Duchenne Muscular Dystrophy Sales and Market Share by Regions (2015-2020)
  4.1.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Regions (2015-2020)
4.2 Europe Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
4.3 APAC Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
4.4 North America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
4.5 South America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)

5 EUROPE DUCHENNE MUSCULAR DYSTROPHY MARKET SIZE CATEGORIZED BY COUNTRIES

5.1 Europe Duchenne Muscular Dystrophy Revenue and Market Share by Countries
  5.1.1 Europe Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
  5.1.2 Germany Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  5.1.3 UK Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  5.1.4 France Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  5.1.5 Russia Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  5.1.6 Italy Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  5.1.7 Spain Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
5.2 Europe Duchenne Muscular Dystrophy Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Duchenne Muscular Dystrophy Revenue and Market Share by Type (2015-2020)
5.4 Europe Duchenne Muscular Dystrophy Revenue and Market Share by Application (2015-2020)

6 ASIA-PACIFIC DUCHENNE MUSCULAR DYSTROPHY MARKET SIZE CATEGORIZED BY COUNTRIES

6.1 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Market Share by Countries
  6.1.1 Asia-Pacific Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
  6.1.2 China Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  6.1.3 Japan Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  6.1.4 Korea Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  6.1.5 India Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  6.1.6 Southeast Asia Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  6.1.7 Australia Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
6.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue (Value) by Players (2018-2020)
6.3 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Market Share by Type (2015-2020)
6.4 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Market Share by Application (2015-2020)

7 NORTH AMERICA DUCHENNE MUSCULAR DYSTROPHY MARKET SIZE CATEGORIZED BY COUNTRIES

7.1 North America Duchenne Muscular Dystrophy Revenue and Market Share by Countries
  7.1.1 North America Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
  7.1.2 United States Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  7.1.3 Canada Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  7.1.4 Mexico Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
7.2 North America Duchenne Muscular Dystrophy Revenue (Value) by Players (2018-2020)
7.3 North America Duchenne Muscular Dystrophy Revenue and Market Share by Type (2015-2020)
7.4 North America Duchenne Muscular Dystrophy Revenue and Market Share by Application (2015-2020)

8 SOUTH AMERICA DUCHENNE MUSCULAR DYSTROPHY MARKET SIZE CATEGORIZED BY COUNTRIES

8.1 South America Duchenne Muscular Dystrophy Revenue and Market Share by Countries
  8.1.1 South America Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
  8.1.2 Brazil Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
8.2 South America Duchenne Muscular Dystrophy Revenue (Value) by Players (2018-2020)
8.3 South America Duchenne Muscular Dystrophy Revenue and Market Share by Type (2015-2020)
8.4 South America Duchenne Muscular Dystrophy Revenue and Market Share by Application (2015-2020)

9 MIDDLE EAST AND AFRICA DUCHENNE MUSCULAR DYSTROPHY MARKET SIZE CATEGORIZED BY COUNTRIES

9.1 Middle East and Africa Duchenne Muscular Dystrophy Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
  9.1.2 GCC Countries Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  9.1.3 Turkey Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  9.1.4 Egypt Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
  9.1.5 South Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
9.2 Middle East and Africa Duchenne Muscular Dystrophy Revenue (Value) by Players (2018-2020)
9.3 Middle East and Africa Duchenne Muscular Dystrophy Revenue and Market Share by Type (2015-2020)
9.4 Middle East and Africa Duchenne Muscular Dystrophy Revenue and Market Share by Application (2015-2020)

10 GLOBAL DUCHENNE MUSCULAR DYSTROPHY MARKET SEGMENT BY TYPE

10.1 Global Duchenne Muscular Dystrophy Revenue and Market Share by Type (2015-2020)
10.2 Global Duchenne Muscular Dystrophy Market Forecast by Type (2020-2025)
10.3 Pain Management Drugs Revenue Growth Rate
10.4 Corticosteroids Revenue Growth Rate
10.5 Prednisolone Revenue Growth Rate
10.6 Prednisone Revenue Growth Rate
10.7 Deflazacort Revenue Growth Rate
11.1 Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2015-2020)
11.2 Global Duchenne Muscular Dystrophy Market Forecast by Application (2020-2025)
11.3 Hospitals Revenue Growth Rate (2015-2025)
11.4 Clinics Revenue Growth Rate (2015-2025)
11.5 Home Care Settings Revenue Growth Rate (2015-2025)
12.1 Global Duchenne Muscular Dystrophy Market Size Forecast (2020-2025)
12.2 Duchenne Muscular Dystrophy Market Forecast by Regions (2020-2025)
12.3 Europe Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
12.4 APAC Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
12.5 North America Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
12.6 South America Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
12.7 Middle East & Africa Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)

13 ANALYSIS OF DUCHENNE MUSCULAR DYSTROPHY INDUSTRY KEY VENDORS

13.1 Bristol-Myers Squibb
  13.1.1 Company Details
  13.1.2 Product Information
  13.1.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.1.4 Main Business Overview
  13.1.5 Bristol-Myers Squibb News
13.2 FibroGen (U.S.)
  13.2.1 Company Details
  13.2.2 Product Information
  13.2.3 FibroGen (U.S.) Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.2.4 Main Business Overview
  13.2.5 FibroGen (U.S.) News
13.3 Italfarmaco (Italy)
  13.3.1 Company Details
  13.3.2 Product Information
  13.3.3 Italfarmaco (Italy) Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.3.4 Main Business Overview
  13.3.5 Italfarmaco (Italy) News
13.4 Marathon
  13.4.1 Company Details
  13.4.2 Product Information
  13.4.3 Marathon Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.4.4 Main Business Overview
  13.4.5 Marathon News
13.5 NS Pharma (U.S.)
  13.5.1 Company Details
  13.5.2 Product Information
  13.5.3 NS Pharma (U.S.) Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.5.4 Main Business Overview
  13.5.5 NS Pharma (U.S.) News
13.6 PTC Therapeutics (U.S.)
  13.6.1 Company Details
  13.6.2 Product Information
  13.6.3 PTC Therapeutics (U.S.) Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.6.4 Main Business Overview
  13.6.5 PTC Therapeutics (U.S.) News
13.7 Pfizer
  13.7.1 Company Details
  13.7.2 Product Information
  13.7.3 Pfizer Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.7.4 Main Business Overview
  13.7.5 Pfizer News
13.8 ReveraGen BioPharma (U.S.)
  13.8.1 Company Details
  13.8.2 Product Information
  13.8.3 ReveraGen BioPharma (U.S.) Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.8.4 Main Business Overview
  13.8.5 ReveraGen BioPharma (U.S.) News
13.9 Santhera Pharmaceuticals (Switzerland)
  13.9.1 Company Details
  13.9.2 Product Information
  13.9.3 Santhera Pharmaceuticals (Switzerland) Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.9.4 Main Business Overview
  13.9.5 Santhera Pharmaceuticals (Switzerland) News
13.10 Sarepta Therapeutics (U.S.)
  13.10.1 Company Details
  13.10.2 Product Information
  13.10.3 Sarepta Therapeutics (U.S.) Duchenne Muscular Dystrophy Revenue and Gross Margin (2018-2020)
  13.10.4 Main Business Overview
  13.10.5 Sarepta Therapeutics (U.S.) News

15 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Duchenne Muscular Dystrophy Picture
Figure Research Programs/Design for This Report
Figure Global Duchenne Muscular Dystrophy Market by Regions (2019)
Table Global Market Duchenne Muscular Dystrophy Comparison by Regions (M USD) 2019-2025
Table Global Duchenne Muscular Dystrophy Value Growth (CAGR) (2019-2025) by Type
Figure Global Value Market Share of Duchenne Muscular Dystrophy by Type in 2019
Figure Pain Management Drugs Picture
Figure Corticosteroids Picture
Figure Prednisolone Picture
Figure Prednisone Picture
Figure Deflazacort Picture
Figure Hospitals Picture
Figure Clinics Picture
Figure Home Care Settings Picture
Table Global Duchenne Muscular Dystrophy Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Duchenne Muscular Dystrophy Vendors (Revenue) Market Share in 2019
Figure Top 10 Duchenne Muscular Dystrophy Vendors (Revenue) Market Share in 2019
Table Date of Key Vendors Enter into Duchenne Muscular Dystrophy Market
Table Key Vendors Duchenne Muscular Dystrophy Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Related Markets
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global Duchenne Muscular Dystrophy Revenue (Million USD) by Regions (2015-2020)
Table Global Duchenne Muscular Dystrophy Revenue Market Share by Regions (2015-2020)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2019
Figure Europe Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure APAC Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure North America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure South America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Middle East & Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Europe Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table Europe Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
Table Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2019
Figure Germany Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure UK Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure France Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Russia Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Italy Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Spain Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table Europe Duchenne Muscular Dystrophy Revenue by Player (2018-2020)
Figure Europe Duchenne Muscular Dystrophy Revenue Market Share by Player in 2019
Table Europe Duchenne Muscular Dystrophy Revenue by Type (2015-2020)
Table Europe Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Table Europe Duchenne Muscular Dystrophy Revenue by Application (2015-2020)
Table Europe Duchenne Muscular Dystrophy Revenue Share by Application (2015-2020)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific 118 Revenue Market Share by Countries in 2019
Figure China Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Japan Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Korea Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure India Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Australia Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Player (2018-2020)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Player in 2019
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Type (2015-2020)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Application (2015-2020)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Share by Application (2015-2020)
Figure North America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table North America Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
Table North America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure North America Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2019
Figure United States Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Canada Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Mexico Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table North America Duchenne Muscular Dystrophy Revenue by Player (2018-2020)
Figure North America Duchenne Muscular Dystrophy Revenue Market Share by Player in 2019
Table North America Duchenne Muscular Dystrophy Revenue by Type (2015-2020)
Table North America Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Table North America Duchenne Muscular Dystrophy Revenue by Application (2015-2020)
Table North America Duchenne Muscular Dystrophy Revenue Share by Application (2015-2020)
Figure South America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table South America Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
Table South America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure South America Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2019
Figure Brazil Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table South America Duchenne Muscular Dystrophy Revenue by Player (2018-2020)
Figure South America Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2019
Table South America Duchenne Muscular Dystrophy Revenue by Type (2015-2020)
Table South America Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Table South America Duchenne Muscular Dystrophy Revenue by Application (2015-2020)
Table South America Duchenne Muscular Dystrophy Revenue Share by Application (2015-2020)
Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Duchenne Muscular Dystrophy Revenue by Countries (2015-2020)
Table Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Countries in 2019
Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2019
Figure GCC Countries Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Egypt Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure Turkey Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Figure South Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Duchenne Muscular Dystrophy Revenue by Player (2018-2020)
Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Player in 2019
Table Middle East and Africa Duchenne Muscular Dystrophy Revenue by Type (2015-2020)
Table Middle East and Africa Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Table Middle East and Africa Duchenne Muscular Dystrophy Revenue by Application (2015-2020)
Table Middle East and Africa Duchenne Muscular Dystrophy Revenue Share by Application (2015-2020)
Table Global Duchenne Muscular Dystrophy Revenue (Million USD) by Type (2015-2020)
Table Global Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2019
Table Global Duchenne Muscular Dystrophy Revenue Forecast by Type (2020-2025)
Figure Global Duchenne Muscular Dystrophy Market Share Forecast by Type (2020-2025)
Figure Global Pain Management Drugs Revenue Growth Rate (2015-2025)
Figure Global Corticosteroids Revenue Growth Rate (2015-2025)
Figure Global Prednisolone Revenue Growth Rate (2015-2025)
Figure Global Prednisone Revenue Growth Rate (2015-2025)
Figure Global Deflazacort Revenue Growth Rate (2015-2025)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Application (2015-2020)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Application in 2019
Figure Global Duchenne Muscular Dystrophy Revenue Forecast by Application (2020-2025)
Figure Global Duchenne Muscular Dystrophy Market Share Forecast by Application (2020-2025)
Figure Global Hospitals Revenue Growth Rate (2015-2025)
Figure Global Clinics Revenue Growth Rate (2015-2025)
Figure Global Home Care Settings Revenue Growth Rate (2015-2025)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Regions (2020-2025)
Figure Europe Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
Figure North America Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
Figure South America Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Forecast (2020-2025)
Table Bristol-Myers Squibb Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of Bristol-Myers Squibb
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure Bristol-Myers Squibb Duchenne Muscular Dystrophy Market Share (2018-2020)
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table FibroGen (U.S.) Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of FibroGen (U.S.)
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure FibroGen (U.S.) Duchenne Muscular Dystrophy Market Share (2018-2020)
Table FibroGen (U.S.) Main Business
Table FibroGen (U.S.) Recent Development
Table Italfarmaco (Italy) Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of Italfarmaco (Italy)
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure Italfarmaco (Italy) Duchenne Muscular Dystrophy Market Share (2018-2020)
Table Italfarmaco (Italy) Main Business
Table Italfarmaco (Italy) Recent Development
Table Marathon Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of Marathon
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure Marathon Duchenne Muscular Dystrophy Market Share (2018-2020)
Table Marathon Main Business
Table Marathon Recent Development
Table NS Pharma (U.S.) Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of NS Pharma (U.S.)
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure NS Pharma (U.S.) Duchenne Muscular Dystrophy Market Share (2018-2020)
Table NS Pharma (U.S.) Main Business
Table NS Pharma (U.S.) Recent Development
Table PTC Therapeutics (U.S.) Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of PTC Therapeutics (U.S.)
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure PTC Therapeutics (U.S.) Duchenne Muscular Dystrophy Market Share (2018-2020)
Table PTC Therapeutics (U.S.) Main Business
Table PTC Therapeutics (U.S.) Recent Development
Table Pfizer Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of Pfizer
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure Pfizer Duchenne Muscular Dystrophy Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table ReveraGen BioPharma (U.S.) Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of ReveraGen BioPharma (U.S.)
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure ReveraGen BioPharma (U.S.) Duchenne Muscular Dystrophy Market Share (2018-2020)
Table ReveraGen BioPharma (U.S.) Main Business
Table ReveraGen BioPharma (U.S.) Recent Development
Table Santhera Pharmaceuticals (Switzerland) Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of Santhera Pharmaceuticals (Switzerland)
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure Santhera Pharmaceuticals (Switzerland) Duchenne Muscular Dystrophy Market Share (2018-2020)
Table Santhera Pharmaceuticals (Switzerland) Main Business
Table Santhera Pharmaceuticals (Switzerland) Recent Development
Table Sarepta Therapeutics (U.S.) Company Profile
Figure Duchenne Muscular Dystrophy Product Picture and Specifications of Sarepta Therapeutics (U.S.)
Table Duchenne Muscular Dystrophy Revenue (M USD) and Gross Margin 2018-2020
Figure Sarepta Therapeutics (U.S.) Duchenne Muscular Dystrophy Market Share (2018-2020)
Table Sarepta Therapeutics (U.S.) Main Business
Table Sarepta Therapeutics (U.S.) Recent Development